arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Myriad Genetics, Inc.

MYGN Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances
$3.20
▲ +0.3% Today
as of Sep 4, 16:52 ET
Last 30 days -40.04% Jul 28 → Sep 04
$2.66 $3.39 $4.11 $4.84 $5.57 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$3.19
High
$3.20
Low
$3.15
Volume
$805,851
Avg Vol
$2M
Mkt Cap
$303M
P/E (TTM)
Beta
52w High
$8.59
52w Low
$2.74
Div Yield
Shares Out
$96M

Recent Press Releases & News last 60 days · 22 items

▸ Show all 22 press releases & news Free account →

Overview

52-week range
$2.74
$8.59
8% of range
Avg surprise (last 3)
+21.0%
Avg reaction (last 2)
-1.9%
50% positive
Latest IV / EM
150%
EM ±23.4% · $3 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.42$-1.08$-0.74$-0.40$-0.06 Actual $-0.67Actual $-1.42Actual $-0.75Actual $-0.29Actual $-0.41Actual $-0.24Actual $-0.14Est $-0.17Actual $-0.06Est $-0.11Actual $-0.29Actual $-0.16Est $-0.16Actual $-0.46 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-330M$-192M$-53M$85M$224M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.46 financials
Tue May 5, 2026Mar/2026 $-0.16 $-0.16 0.0% -14.3% +1.8% earnings
Tue Sep 30, 2025Sep 2025 $-0.29 financials
Tue Aug 5, 2025Jun/2025 $-0.06 $-0.11 +45.5% earnings
Tue May 6, 2025Mar/2025 $-0.14 $-0.17 +17.6% -5.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.24 financials
Sun Jun 30, 2024Jun 2024 $-0.41 financials
Sun Mar 31, 2024Mar 2024 $-0.29 financials
Sat Sep 30, 2023Sep 2023 $-0.75 financials
Fri Jun 30, 2023Jun 2023 $-1.42 financials
Fri Mar 31, 2023Mar 2023 $-0.67 financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$191M$200M$206M$213M$196M$213M
Cost of revenue$64M$63M$62M$61M$62M$64M
Gross profit$127M$138M$144M$152M$134M$150M
Operating income$-39M$-31M$-23M$-329M$-29M$-20M
Net income$-43M$-34M$-27M$-330M$-100,000$-22M
EPS (diluted)$-0.46$-0.36$-0.29$-3.57$-0.24

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$115M$124M$150M$145M$74M$92M$102M$100M
Inventory$31M$28M$31M$32M$29M$28M$28M$26M
Total current assets$289M$313M$333M$345M$284M$287M$298M$293M
Total assets$639M$674M$707M$728M$677M$1.01B$1.03B$1.08B
Long-term debt$121M$120M$120M$120M$0$59M$40M$39M
Total liabilities$335M$336M$339M$355M$289M$301M$326M$350M
Total equity$304M$337M$368M$373M$388M$705M$701M$732M

Implied volatility — last 90 days

57%159%261%364%466% Jun 07 — IV 158% · EM ±21.9%Jun 08 — IV 233% · EM ±30.8%Jun 12 — IV 260% · EM ±26.6%Jun 19 — IV 82% · EM ±18.2%Jun 22 — IV 144% · EM ±30.1%Jun 23 — IV 158% · EM ±32.4%Jun 24 — IV 57% · EM ±11.5%Jun 25 — IV 145% · EM ±28.4%Jun 26 — IV 92% · EM ±17.6%Jun 29 — IV 109% · EM ±19.2%Jul 06 — IV 99% · EM ±13.7%Jul 09 — IV 90% · EM ±10.7%Jul 13 — IV 112% · EM ±9.4%Jul 14 — IV 114% · EM ±8.3%Jul 15 — IV 136% · EM ±8.0%Jul 21 — IV 115% · EM ±26.6%Jul 22 — IV 97% · EM ±22.1%Jul 23 — IV 148% · EM ±33.3%Jul 24 — IV 60% · EM ±13.4%Jul 27 — IV 145% · EM ±30.3%Jul 28 — IV 220% · EM ±45.1%Jul 29 — IV 79% · EM ±15.9%Jul 30 — IV 356% · EM ±69.7%Jul 31 — IV 59% · EM ±11.3%Aug 03 — IV 75% · EM ±13.2%Aug 04 — IV 101% · EM ±17.4%Aug 06 — IV 467% · EM ±75.5%Aug 20 — IV 335% · EM ±14.0%Aug 24 — IV 149% · EM ±31.1%Aug 25 — IV 215% · EM ±43.9%Aug 26 — IV 120% · EM ±24.0%Aug 27 — IV 120% · EM ±23.6%Aug 28 — IV 132% · EM ±25.3%Aug 31 — IV 131% · EM ±23.3%Sep 01 — IV 114% · EM ±19.7%Sep 02 — IV 139% · EM ±23.2%Sep 03 — IV 144% · EM ±23.2%Sep 04 — IV 150% · EM ±23.4%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.